Pay T W, Hingley P J
Vaccine. 1987 Mar;5(1):60-4. doi: 10.1016/0264-410x(87)90011-9.
An analysis was made of data from potency tests on fifteen batches of monovalent foot-and-mouth disease vaccine, comprising five batches each of type O, type A and type C. Regressions were calculated for the relation of percentage protection (probit) versus log 140S antigen dose and for the serum neutralizing antibody titre (log SN50) versus log 140S antigen dose. Type O vaccines required a far higher level (220 ng) of 140S antigen to achieve a 50% protection level (PA50) in cattle than did type A (2.4 ng) and type C (4.36 ng) vaccines. Type O antigen, dose for dose, was as effective at provoking neutralizing antibody as the types A and C antigens. Thus, it would appear that a far higher log SN50 value (2.14) was required for type O vaccines to equate with 50% protection of cattle than was required for type A (1.17) and type C (1.41) vaccines. Prior to 1977, however, the PA50 value for type O vaccine strain was only 1.34 and it was concluded that an antigenic shift was the most likely cause for the large difference between that value and the current PA50 value.
对15批单价口蹄疫疫苗效力测试的数据进行了分析,其中包括O型、A型和C型各5批。计算了百分比保护率(概率单位)与log 140S抗原剂量之间的回归关系,以及血清中和抗体滴度(log SN50)与log 140S抗原剂量之间的回归关系。与A型疫苗(2.4纳克)和C型疫苗(4.36纳克)相比,O型疫苗在牛身上达到50%保护水平(PA50)所需的140S抗原水平要高得多(220纳克)。相同剂量下,O型抗原激发中和抗体的效果与A型和C型抗原相同。因此,与A型疫苗(1.17)和C型疫苗(1.41)相比,O型疫苗要达到牛的50%保护水平,似乎需要高得多的log SN50值(2.14)。然而,在1977年之前,O型疫苗株的PA50值仅为1.34,得出的结论是,抗原转变最有可能是该值与当前PA50值存在巨大差异的原因。